AAAAAA
Results:
1-9
|
Results: 9
Authors:
FOUNTZILAS G
DIMOPOULOS M
PAPADIMITRIOU C
ARAVANTINOS G
BRIASSOULIS E
BAFALOUKOS D
PAPAKOSTAS P
PAVLIDIS N
SKARLOS D
Citation: G. Fountzilas et al., DOSE-DENSE SEQUENTIAL ADJUVANT CHEMOTHERAPY WITH EPIRUBICIN, PACLITAXEL AND CMF IN PATIENTS WITH OPERABLE BREAST-CANCER AND GREATER-THAN-OR-EQUAL-TO-10 POSITIVE AXILLARY NODES, Annals of oncology, 9, 1998, pp. 685-685
Authors:
KALOGERAFOUNTZILA A
KOSMIDIS P
BACOYIANNIS C
NICOLAOU A
SAMANTAS E
BRIASSOULIS E
PAVLIDIS N
SKARLOS D
DANILIDIS J
FOUNTZILAS G
Citation: A. Kalogerafountzila et al., PROGNOSTIC FACTORS INFLUENCING COMPLETE RESPONSE TO TREATMENT AND SURVIVAL OF PATIENTS WITH NASOPHARYNGEAL CANCER, Anticancer research, 18(1B), 1998, pp. 587-593
Authors:
FOUNTZILAS G
ATHANASSIADES A
KALOGERAFOUNTZILA A
SAMANTAS E
BACOYIANNIS C
BRIASSOULIS E
PAVLIDIS N
KOSMIDIS P
SKARLOS D
Citation: G. Fountzilas et al., PACLITAXEL IN COMBINATION WITH CARBOPLATIN OR GEMCITABINE FOR THE TREATMENT OF ADVANCED HEAD AND NECK-CANCER, Seminars in oncology, 24(6), 1997, pp. 28-32
Authors:
KOSMIDIS PA
TSAVARIS N
SKARLOS D
THEOCHARIS D
SAMANTAS E
PAVLIDIS N
BRIASSOULIS E
FOUNTZILAS G
Citation: Pa. Kosmidis et al., FLUOROURACIL AND LEUCOVORIN WITH OR WITHOUT INTERFERON ALFA-2B IN ADVANCED COLORECTAL-CANCER - ANALYSIS OF A PROSPECTIVE RANDOMIZED PHASE-III TRIAL, Journal of clinical oncology, 14(10), 1996, pp. 2682-2687
Authors:
PAVLIDIS N
BRIASSOULIS E
BAI M
FOUNTZILAS G
AGNANTIS N
Citation: N. Pavlidis et al., OVEREXPRESSION OF C-MYC, RAS AND C-ERBB-2 ONCOPROTEINS IN CARCINOMA OF UNKNOWN PRIMARY ORIGIN, Anticancer research, 15(6B), 1995, pp. 2563-2567
Authors:
PAVLIDIS N
NICOLAIDES C
KLOUVAS G
BRIASSOULIS E
Citation: N. Pavlidis et al., IS THE COMBINATION OF 5-FLUOROURACIL AND FOLINIC ACID EFFECTIVE IN ADVANCED GASTRIC-CARCINOMA - RESULTS OF A PILOT-STUDY AND REVIEW OF THE LITERATURE, Journal of chemotherapy, 6(6), 1994, pp. 417-422
Authors:
PAVLIDIS NA
BAIRAKTARI E
KALEFEZRA J
NICOLAIDES C
BRIASSOULIS E
SEFERIADIS C
FOUNTZILAS G
Citation: Na. Pavlidis et al., THE VALUE OF CA-125 DETERMINATION IN THE SERUM OF PATIENTS WITH NON-HODGKINS-LYMPHOMAS - A PRELIMINARY-REPORT, Journal of experimental & clinical cancer research, 13(2), 1994, pp. 135-138
Authors:
ECONOMOPOULOS T
STATHAKIS N
ALEXOPOULOS C
PAVLIDIS N
CONSTANTINIDOU M
BRIASSOULIS E
PAPAGEORGIOU E
DERVENOULAS J
PAPPA V
VASLAMATZIS M
RAPTIS S
Citation: T. Economopoulos et al., 2ND MALIGNANCIES FOLLOWING TREATMENT FOR HODGKINS-DISEASE - A GREEK EXPERIENCE, Haematologica, 79(3), 1994, pp. 273-276
Authors:
PAVLIDIS N
KALEFEZRA J
BRIASSOULIS E
SKARLOS D
KOSMIDIS P
SAFERIADIS K
BAIRAKTARI E
BAFALOUKOS D
MARAVEGIAS A
THEOHARIS D
FOUNTZILAS G
Citation: N. Pavlidis et al., EVALUATION OF 6 TUMOR-MARKERS IN PATIENTS WITH CARCINOMA OF UNKNOWN PRIMARY, Medical and pediatric oncology, 22(3), 1994, pp. 162-167
Risultati:
1-9
|